EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $318,000 | -30.3% | 6,635 | -33.1% | 0.02% | -39.3% |
| Q1 2020 | $456,000 | -28.1% | 9,920 | -6.0% | 0.03% | +12.0% |
| Q4 2019 | $634,000 | +17.6% | 10,550 | +10.8% | 0.02% | +4.2% |
| Q3 2019 | $539,000 | -42.1% | 9,525 | -43.0% | 0.02% | -33.3% |
| Q2 2019 | $931,000 | -35.3% | 16,725 | -12.1% | 0.04% | +2.9% |
| Q2 2018 | $1,440,000 | +14.1% | 19,030 | -20.6% | 0.04% | +25.0% |
| Q1 2018 | $1,262,000 | -9.1% | 23,955 | -7.9% | 0.03% | 0.0% |
| Q4 2017 | $1,389,000 | -11.0% | 26,005 | -0.7% | 0.03% | -12.5% |
| Q3 2017 | $1,561,000 | – | 26,180 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |